Investigation of Factors Causing Knee Hyperextension During Walking in Chronic Stroke Patients

February 26, 2024 updated by: Suleyman Korkusuz, Hacettepe University

Investigation of Factors Causing Knee Hyperextension During Walking in Chronic Stroke Patients by Electromyographic Method

In this study, it is aimed to examine the factors that cause knee hyperextension in chronic stroke patients. Although the presence of weakness or spasticity in the quadriceps muscle, weakness or spasticity in the plantar flexors, and weakness of the dorsiflexors, hamstrings and gastrocnemius muscle are shown in the literature as the cause of hyperextension of the affected knee in hemiplegic patients, there is a comprehensive study that shows the effect of both muscle strength and spasticity in the lower extremity muscles. there are no studies.

The hypotheses of the study are:

Hypothesis 1:

H0: There is no relationship between knee hyperextension in the stance phase of gait and lower extremity muscle strength in stroke patients.

H1: There is a relationship between knee hyperextension in the stance phase of gait and lower extremity muscle strength in stroke patients.

Hypothesis 2; H0: There is no relationship between knee hyperextension in the stance phase of gait and lower extremity spasticity in stroke patients.

H1: There is a relationship between knee hyperextension in the stance phase of gait and lower extremity spasticity in stroke patients.

Hypothesis 3; H0: There is no relationship between knee hyperextension and electromyographic muscle activations in chronic stroke patients.

H1: There is a relationship between knee hyperextension and electromyographic muscle activations in chronic stroke patients.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

31

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ankara
      • Altındağ, Ankara, Turkey, 06100
        • Hacettepe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Chronic Stroke Patients with Knee Hyperextension

Description

Inclusion Criteria:

  • Being between the ages of 40-65
  • At least 6 months have passed since the stroke
  • Ambulation with or without a walking aid (walker, cane, or tripod)
  • Being between 0-3 points according to the Modified Rankin Score
  • Getting a score of 24 or higher on the Mini Mental Test
  • Presence of hyperextension in the stance phase of gait
  • Volunteering to participate in the study

Exclusion Criteria:

  • Having a history of more than one stroke
  • Known presence of dementia
  • Having a known orthopedic, psychiatric or other neurological disease
  • Having a situation that prevents communication
  • Having a history of surgery involving lower extremities and gait

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Chronic stroke patients with knee hyperextension

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Movement Analysis
Time Frame: Baseline
Reflective signs will be placed at certain anatomical points of the participants. Participants will be asked to walk a distance of 5 meters. The three-dimensional positions of these reflective marks will be recorded with the 8-camera Vicon motion capture system. Then it will be examined in computer environment using Blade software.
Baseline
Electromyographic Measurements
Time Frame: Baseline
Electromyography (EMG) is frequently used in the literature for motion analysis evaluations. It shows the amplitude of the electrical activity of the muscles. In this study, 8-channel Delsys Bagnoli desktop cable electromyography system (Delsys (Delsys Inc., USA)) will be used. EMG; It shows whether the muscles are active during movement, when they are active and how active they are. In this study, the muscles to be measured by EMG: tibialis anterior, medial gastrocnemius, medial hamstrings, rectus femoris, gluteus medius and the lower part of the latismus dorsi are planned.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle Strength Evaluation
Time Frame: Baseline
Manual muscle testing will be performed on patients' hip flexors, hip extensors, hip abductors, hip adductors, knee flexors, knee extensors, dorsiflexors, and plantar flexors. A score between 0 and 5 will be given according to the manual muscle test, the ability of the muscles to move against gravity in certain positions, and the resistance of the movement against gravity.
Baseline
Spasticity Evaluation
Time Frame: Baseline
The spasticity of the lower extremity muscles (quadriceps, hip extensors, hip adductors, hip internal retractors and plantar flexors) will be evaluated according to the Modified Ashworth Scale. The spasticity assessment will be scored between 0 and 4 according to the resistance of the muscles to passive movement.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Kadriye Armutlu, Prof. Dr., Hacettepe University
  • Study Chair: Büşra Seçkinoğulları, MSc, Hacettepe University
  • Study Chair: Sibel Kibar, Assoc. Prof., Atılım University
  • Study Chair: Serdar Arıtan, Asst.Prof, Hacettepe University
  • Study Chair: Nihat Özgören, MSc, Hacettepe University
  • Study Chair: Ali Naim Ceren, Msc, Hacettepe University
  • Principal Investigator: Süleyman Korkusuz, MSc, Hacettepe University
  • Study Chair: Ayla Fil Balkan, Assoc.Prof, Hacettepe University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 20, 2022

Primary Completion (Actual)

October 11, 2023

Study Completion (Actual)

November 15, 2023

Study Registration Dates

First Submitted

August 22, 2022

First Submitted That Met QC Criteria

August 22, 2022

First Posted (Actual)

August 24, 2022

Study Record Updates

Last Update Posted (Estimated)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 26, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe